Doug Wilson Photo: supplied
Doug Wilson is a medical academic, author most recently of Aging Well: How to Navigate Life’s Journey in Your Later Years, and our regular correspondent from the other side of 80.
This week, he'll be discussing approval by the US Food and Drug Administration (FDA) of the first new drug for Alzheimer's disease in 18 years. Its approval has sparked debate about whether the drug is effective, and the FDA has narrowed its recommendation around who should receive it. So what does the approval mean?
Doug also discusses the creation of a new vaccine against malaria that is hoped to be more effective than current vaccine, Mosquirix.
Photo: AFP
